CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Renal impairment under triple therapy with boceprevir in German real-life: evidence for a pivotal role for peginterferon/ribavirin backbone, female gender and age elder than 50 years
DOI 10.1055/s-0034-1397252
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Recently, renal impairment corresponding to renal insufficiency stage 3 has been reported in about 5% of patients treated for HCV genotype 1 infection with telaprevir or boceprevir (S Mauss et al., Hepatology 2014; 59:46 – 48). The present interim analysis of the NOVUS observational study was conducted to determine the frequency of stage 2 and stage 3 renal insufficiencies and to elucidate associated ris…
Zitieren
Zitierempfehlung
P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer (2015) Renal impairment under triple therapy with boceprevir in German real-life: evidence for a pivotal role for peginterferon/ribavirin backbone, female gender and age elder than 50 years. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397252
Mit CareLit weiterarbeiten